Literature DB >> 25952561

Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.

K T Hanssen1,2, A G Beiske1, N I Landrø3, D Hofoss4, E Hessen2,3,5.   

Abstract

BACKGROUND: The evidence base in cognitive rehabilitation in multiple sclerosis (MS) is still sparse.
OBJECTIVE: The aim of the study was to investigate the effects of cognitive rehabilitation on cognitive and executive coping, psychological well-being and psychological aspects of health-related quality of life (HRQoL) in patients with MS.
METHODS: One hundred and twenty patients with cognitive complaints, taking part in a 4-week multidisciplinary rehabilitation, were randomized to an intervention group (n = 60) and a control group (n = 60). Both groups underwent neuropsychological assessment with subsequent feedback and took part in general multidisciplinary MS rehabilitation. Additionally, the intervention group participated in cognitive group sessions as well as individual sessions. The main focus was to formulate Goal Attainment Scaling goals for coping with cognitive challenges. For 3 months past rehabilitation, the intervention group received biweekly telephone follow-up, focusing on goal attainment.
RESULTS: Executive functioning improved significantly from baseline to four and 7 months in both groups. Improvements in psychological well-being and psychological aspects of HRQoL occurred only in the intervention group.
CONCLUSION: Multicomponent cognitive rehabilitation administered within the context of multidisciplinary rehabilitation can improve psychological well-being and psychological aspects of HRQoL.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  multiple sclerosis; neuropsychology; quality of life; rehabilitation

Mesh:

Year:  2015        PMID: 25952561     DOI: 10.1111/ane.12420

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.

Authors:  Nadina B Lincoln; Lucy E Bradshaw; Cris S Constantinescu; Florence Day; Avril Er Drummond; Deborah Fitzsimmons; Shaun Harris; Alan A Montgomery; Roshan das Nair
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

Review 2.  Memory rehabilitation for people with multiple sclerosis.

Authors:  Lauren A Taylor; Jacqueline R Mhizha-Murira; Laura Smith; Kristy-Jane Potter; Dana Wong; Nikos Evangelou; Nadina B Lincoln; Roshan das Nair
Journal:  Cochrane Database Syst Rev       Date:  2021-10-18

Review 3.  Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation.

Authors:  Arseny A Sokolov; Petr Grivaz; Riley Bove
Journal:  Curr Treat Options Neurol       Date:  2018-10-22       Impact factor: 3.598

4.  Focus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment.

Authors:  Jessica Podda; Andrea Tacchino; Ludovico Pedullà; Margherita Monti Bragadin; Mario Alberto Battaglia; Giampaolo Brichetto
Journal:  Mult Scler       Date:  2020-10-13       Impact factor: 5.855

5.  Participant Perspectives of Cognitive Rehabilitation for Type 2 Diabetes: Expectations and Impact.

Authors:  Heather E Cuevas; Alexa K Stuifbergen; Catherine Ward
Journal:  J Aging Res       Date:  2018-08-19

6.  A Study Protocol for Occupational Rehabilitation in Multiple Sclerosis.

Authors:  Marco Trombini; Federica Ferraro; Giulia Iaconi; Lucilla Vestito; Fabio Bandini; Laura Mori; Carlo Trompetto; Silvana Dellepiane
Journal:  Sensors (Basel)       Date:  2021-12-17       Impact factor: 3.576

7.  The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot study.

Authors:  Kathleen C Munger; Amy Pacos Martinez; Megan H Hyland
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-08-26

8.  Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial.

Authors:  Thomas Williams; Carmen Tur; Arman Eshaghi; Anisha Doshi; Dennis Chan; Sophie Binks; Henny Wellington; Amanda Heslegrave; Henrik Zetterberg; Jeremy Chataway
Journal:  Mult Scler       Date:  2022-08-09       Impact factor: 5.855

Review 9.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

Review 10.  Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis.

Authors:  Elzbieta Miller; Agnieszka Morel; Justyna Redlicka; Igor Miller; Joanna Saluk
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.